PMID- 21813452 OWN - NLM STAT- MEDLINE DCOM- 20111202 LR - 20220129 IS - 1528-0020 (Electronic) IS - 0006-4971 (Linking) VI - 118 IP - 13 DP - 2011 Sep 29 TI - Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation. PG - 3613-21 LID - 10.1182/blood-2010-06-289207 [doi] AB - Acquisition of homozygous activating growth factor receptor mutations might accelerate cancer progression through a simple gene-dosage effect. Internal tandem duplications (ITDs) of FLT3 occur in approximately 25% cases of acute myeloid leukemia and induce ligand-independent constitutive signaling. Homozygous FLT3-ITDs confer an adverse prognosis and are frequently detected at relapse. Using a mouse knockin model of Flt3-internal tandem duplication (Flt3-ITD)-induced myeloproliferation, we herein demonstrate that the enhanced myeloid phenotype and expansion of granulocyte-monocyte and primitive Lin(-)Sca1(+)c-Kit(+) progenitors in Flt3-ITD homozygous mice can in part be mediated through the loss of the second wild-type allele. Further, whereas autocrine FLT3 ligand production has been implicated in FLT3-ITD myeloid malignancies and resistance to FLT3 inhibitors, we demonstrate here that the mouse Flt3(ITD/ITD) myeloid phenotype is FLT3 ligand-independent. FAU - Kharazi, Shabnam AU - Kharazi S AD - Hematopoietic Stem Cell Laboratory, Lund Stem Cell Center, Lund University Biomedical Center, Lund, Sweden. FAU - Mead, Adam J AU - Mead AJ FAU - Mansour, Anna AU - Mansour A FAU - Hultquist, Anne AU - Hultquist A FAU - Boiers, Charlotta AU - Boiers C FAU - Luc, Sidinh AU - Luc S FAU - Buza-Vidas, Natalija AU - Buza-Vidas N FAU - Ma, Zhi AU - Ma Z FAU - Ferry, Helen AU - Ferry H FAU - Atkinson, Debbie AU - Atkinson D FAU - Reckzeh, Kristian AU - Reckzeh K FAU - Masson, Kristina AU - Masson K FAU - Cammenga, Jorg AU - Cammenga J FAU - Ronnstrand, Lars AU - Ronnstrand L FAU - Arai, Fumio AU - Arai F FAU - Suda, Toshio AU - Suda T FAU - Nerlov, Claus AU - Nerlov C FAU - Sitnicka, Ewa AU - Sitnicka E FAU - Jacobsen, Sten Eirik W AU - Jacobsen SE LA - eng GR - G0701761/MRC_/Medical Research Council/United Kingdom GR - G0801073/MRC_/Medical Research Council/United Kingdom GR - G0900892/MRC_/Medical Research Council/United Kingdom GR - G84/6443/MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110802 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Membrane Proteins) RN - 0 (flt3 ligand protein) RN - EC 2.7.10.1 (Flt3 protein, mouse) RN - EC 2.7.10.1 (fms-Like Tyrosine Kinase 3) SB - IM MH - Alleles MH - Animals MH - Bone Marrow Cells/metabolism/pathology/physiology MH - Cell Proliferation MH - Cells, Cultured MH - Gene Dosage/*physiology MH - Gene Duplication/*physiology MH - Gene Knock-In Techniques MH - Loss of Heterozygosity/genetics/*physiology MH - Male MH - Membrane Proteins/*genetics/metabolism/physiology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Transgenic MH - Myeloproliferative Disorders/*genetics MH - Phenotype MH - Tandem Repeat Sequences/genetics/physiology MH - fms-Like Tyrosine Kinase 3/metabolism/*physiology EDAT- 2011/08/05 06:00 MHDA- 2011/12/13 00:00 CRDT- 2011/08/05 06:00 PHST- 2011/08/05 06:00 [entrez] PHST- 2011/08/05 06:00 [pubmed] PHST- 2011/12/13 00:00 [medline] AID - S0006-4971(20)40455-0 [pii] AID - 10.1182/blood-2010-06-289207 [doi] PST - ppublish SO - Blood. 2011 Sep 29;118(13):3613-21. doi: 10.1182/blood-2010-06-289207. Epub 2011 Aug 2.